Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China flag China · Delayed Price · Currency is CNY
18.54
+0.75 (4.22%)
Apr 28, 2026, 3:04 PM CST

SHE:000623 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,1631,1071,7201,4381,743
Short-Term Investments
---788704
Trading Asset Securities
1,8001,5681,6581,6402,189
Cash & Short-Term Investments
2,9632,6753,3783,8664,635
Cash Growth
10.76%-20.81%-12.62%-16.59%2.71%
Accounts Receivable
1,0011,1571,4071,056964.31
Other Receivables
25.2523.1829.9860.3168.53
Receivables
1,0271,1811,4371,1161,033
Inventory
802.1936.9872.35874.57591.88
Prepaid Expenses
----0.16
Other Current Assets
31.3840.4157.55124.6965.59
Total Current Assets
4,8234,8335,7455,9826,326
Property, Plant & Equipment
2,3562,5582,5342,3392,296
Long-Term Investments
26,47324,64723,00321,89119,637
Other Intangible Assets
404.52437.32435.35365.08359.61
Long-Term Deferred Tax Assets
269.99326.23309.84303.12164.27
Long-Term Deferred Charges
37.63111.57163.96212.25188.02
Other Long-Term Assets
54.0488.3375.7789.8396.53
Total Assets
34,41833,00232,26631,18229,067
Accounts Payable
310.42425.71418.59450.97238.22
Accrued Expenses
113.71106.87148.94183.15111.71
Short-Term Debt
903.021,255678.31651.27355.52
Current Portion of Long-Term Debt
24.07-2,315--
Current Portion of Leases
9.2922.4817.8818.2325.41
Current Income Taxes Payable
3.595.928.2811.5219.31
Current Unearned Revenue
31.6836.2526.2682.2518.36
Other Current Liabilities
618.28611.75834.8817.97687.19
Total Current Liabilities
2,0142,4644,4682,2151,456
Long-Term Debt
1,299995.22-2,3032,211
Long-Term Leases
3.1816.5121.4917.5523.38
Long-Term Unearned Revenue
212.98223.87247.38281.6313.86
Long-Term Deferred Tax Liabilities
1.3620.1730.0326.0624.21
Total Liabilities
3,5313,7204,7674,8444,029
Common Stock
1,1961,1961,1681,1631,163
Additional Paid-In Capital
4,8984,8524,0353,9473,980
Retained Earnings
24,27522,46621,87120,74119,243
Treasury Stock
-420.01-300-720.07-570.07-400.03
Comprehensive Income & Other
717.38814.1856.99753.71873.11
Total Common Equity
30,66729,02827,21226,03424,859
Minority Interest
220.23254.65288.01303.54179.26
Shareholders' Equity
30,88729,28227,50026,33825,039
Total Liabilities & Equity
34,41833,00232,26631,18229,067
Total Debt
2,2392,2893,0322,9902,616
Net Cash (Debt)
724385.96346.02875.842,020
Net Cash Growth
87.58%11.54%-60.49%-56.63%-0.57%
Net Cash Per Share
0.620.330.270.671.60
Filing Date Shares Outstanding
1,1721,1721,1231,1271,139
Total Common Shares Outstanding
1,1721,1801,1231,1271,139
Working Capital
2,8092,3691,2773,7674,870
Book Value Per Share
26.1624.6124.2323.1021.83
Tangible Book Value
30,26228,59026,77625,66924,500
Tangible Book Value Per Share
25.8124.2423.8422.7821.51
Buildings
2,2902,2872,2022,1382,039
Machinery
1,5341,5121,4911,4131,321
Construction In Progress
324.63424.87349.54177.36179.32
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.